HMGCR activity was reduced significantly in PS‐DKO MEFs, in WT cells treated with γ‐secretase inhibitors (DAPT) (Fig 1C), and in AD fibroblasts (Fig EV1B), in agreement with previous observations (Pierrot et al, 2013). Here, HMGCR is linked to Alzheimer disease.